Mirae Asset Global Investments Co., Ltd. Edgewise Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,155 shares of EWTX stock, worth $88,403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,155
Previous 3,392
6.99%
Holding current value
$88,403
Previous $90,000
6.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EWTX
# of Institutions
190Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$421 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$250 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$169 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$164 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$156 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.77B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...